Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-16-117574
Filing Date
2016-05-04
Accepted
2016-05-04 19:23:45
Documents
1
Period of Report
2016-05-02

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3892
  Complete submission text file 0001209191-16-117574.txt   5290
Mailing Address 4745 WILEY POST WAY SUITE 650 C/O ANESTA CORP SALT LAKE CITY UT 84116
Business Address
STANLEY THEODORE H (Reporting) CIK: 0000938296 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35902 | Film No.: 161621159

Mailing Address 10220 SOUTH 51ST STREET SUITE 2 PHOENIX AZ 85044
Business Address 10220 SOUTH 51ST STREET SUITE 2 PHOENIX AZ 85044 602-910-2617
Insys Therapeutics, Inc. (Issuer) CIK: 0001516479 (see all company filings)

EIN.: 510327886 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations